BlossomHill Therapeutics, Inc.
BLSM
Transaktioner
60
Köp
60
Sälj
0
Nettoinsynsflöde
85.4 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
17 dagliga stängningskurserAvkastning efter transaktion
Median-% efter transaktionsdatum| Horisont | Efter köp | Efter sälj | Spridning | Träffsäkerhet köp |
|---|---|---|---|---|
| 1 handelsdagar | 1,50% (60) | –% (0) | – pp | 100% |
| 5 handelsdagar | 1,13% (60) | –% (0) | – pp | 100% |
| 30 handelsdagar | –% (0) | –% (0) | – pp | –% |
| 90 handelsdagar | –% (0) | –% (0) | – pp | –% |
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
60 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-08-10 | ORBIMED ADVISORS LLC | Director | Buy | 1.0 mn | – | – |
| 2026-08-10 | ORBIMED ADVISORS LLC | Director | Buy | 1.0 mn | – | – |
| 2026-08-10 | ORBIMED ADVISORS LLC | Director | Buy | 625 k | 16,00 | 10.0 mn USD |
| 2026-08-10 | GORDON CARL L | Director | Buy | 1.0 mn | – | – |
| 2026-08-10 | GORDON CARL L | Director | Buy | 1.0 mn | – | – |
| 2026-08-10 | GORDON CARL L | Director | Buy | 625 k | 16,00 | 10.0 mn USD |
| 2026-08-10 | GORDON CARL L | Director | Buy | 1.0 mn | – | – |
| 2026-08-10 | GORDON CARL L | Director | Buy | 1.0 mn | – | – |
| 2026-08-10 | GORDON CARL L | Director | Buy | 625 k | 16,00 | 10.0 mn USD |
| 2026-08-10 | ORBIMED ADVISORS LLC | Director | Buy | 1.0 mn | – | – |
| 2026-08-10 | ORBIMED ADVISORS LLC | Director | Buy | 1.0 mn | – | – |
| 2026-08-10 | ORBIMED ADVISORS LLC | Director | Buy | 625 k | 16,00 | 10.0 mn USD |
| 2026-08-10 | ORBIMED ADVISORS LLC | Director | Buy | 1.0 mn | – | – |
| 2026-08-10 | ORBIMED ADVISORS LLC | Director | Buy | 1.0 mn | – | – |
| 2026-08-10 | ORBIMED ADVISORS LLC | Director | Buy | 625 k | 16,00 | 10.0 mn USD |
| 2026-08-10 | Agrawal Sundeep | Director | Buy | 579 k | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.6 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.7 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 313 k | 16,00 | 5.0 mn USD |
| 2026-08-10 | Schmid John P. | Director | Buy | 6 k | 16,00 | 96 k USD |
| 2026-08-10 | Keyes Jason A | Chief Financial Officer | Buy | 700 | 16,00 | 11 k USD |
| 2026-08-10 | Li Yishan | Executive Chairman | Buy | 1.6 mn | – | – |
| 2026-08-10 | Li Yishan | Executive Chairman | Buy | 113 k | – | – |
| 2026-08-10 | Li Yishan | Executive Chairman | Buy | 125 k | – | – |
| 2026-08-10 | Cui Jingrong Jean | President and CEO | Buy | 1.6 mn | – | – |
| 2026-08-10 | Cui Jingrong Jean | President and CEO | Buy | 113 k | – | – |
| 2026-08-10 | Cui Jingrong Jean | President and CEO | Buy | 125 k | – | – |
| 2026-08-10 | Agrawal Sundeep | Director | Buy | 579 k | – | – |
| 2026-08-10 | Liptak Vincent Paul | General Counsel | Buy | 2 k | 16,00 | 35 k USD |
| 2026-08-10 | Liptak Vincent Paul | General Counsel | Buy | 23 k | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.6 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.7 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 313 k | 16,00 | 5.0 mn USD |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.6 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.7 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 313 k | 16,00 | 5.0 mn USD |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.6 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.7 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 313 k | 16,00 | 5.0 mn USD |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.6 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.7 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 313 k | 16,00 | 5.0 mn USD |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.6 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.7 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 313 k | 16,00 | 5.0 mn USD |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.6 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 1.7 mn | – | – |
| 2026-08-10 | Chen Bihua | Director, 10% owner | Buy | 313 k | 16,00 | 5.0 mn USD |
| 2026-08-10 | Cui Jingrong Jean | President and CEO | Buy | 1.6 mn | – | – |
| 2026-08-10 | Cui Jingrong Jean | President and CEO | Buy | 113 k | – | – |
| 2026-08-10 | Cui Jingrong Jean | President and CEO | Buy | 125 k | – | – |
| 2026-08-10 | Keyes Jason A | Chief Financial Officer | Buy | 700 | 16,00 | 11 k USD |
| 2026-08-10 | Li Yishan | Executive Chairman | Buy | 1.6 mn | – | – |
| 2026-08-10 | Li Yishan | Executive Chairman | Buy | 113 k | – | – |
| 2026-08-10 | Li Yishan | Executive Chairman | Buy | 125 k | – | – |
| 2026-08-10 | Liptak Vincent Paul | General Counsel | Buy | 2 k | 16,00 | 35 k USD |
| 2026-08-10 | Liptak Vincent Paul | General Counsel | Buy | 23 k | – | – |
| 2026-08-10 | Schmid John P. | Director | Buy | 6 k | 16,00 | 96 k USD |
| 2026-08-07 | Liptak Vincent Paul | General Counsel | Buy | 3 k | 15,80 | 40 k USD |
| 2026-08-07 | Liptak Vincent Paul | General Counsel | Buy | 3 k | 15,80 | 40 k USD |